Literature DB >> 17962625

VAP-1 and CD73, endothelial cell surface enzymes in leukocyte extravasation.

Sirpa Jalkanen1, Marko Salmi.   

Abstract

Leukocyte extravasation from the blood into tissues is crucial for normal immune surveillance and in inflammation. Traditionally molecules belonging to selectin, chemokine, integrin, and immunoglobulin super families are thought to mediate the multiple adhesive and activation events needed for a successful emigration cascade. Recently, emerging evidence suggests that enzymes expressed on the surface of endothelial cells and leukocytes also contribute to the leukocyte extravasation cascade. Here we briefly review the role of vascular adhesion protein-1 (VAP-1) and CD73, 2 cell surface enzymes, in leukocyte migration form the blood into the tissues. Importantly, specific enzyme inhibitors, gene-deficient mice, and recombinant enzymes have recently unambiguously shown that the catalytic activity of these enzymes regulates the leukocyte traffic. The concept of enzymatic regulation of leukocyte extravasation provides new insight into the multi-step adhesion cascade and opens new possibilities for inhibiting inappropriate inflammatory reaction through the use of small molecule enzyme inhibitors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17962625     DOI: 10.1161/ATVBAHA.107.153130

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  40 in total

Review 1.  Estimating wound age: looking into the future.

Authors:  Rossana Cecchi
Journal:  Int J Legal Med       Date:  2010-09-14       Impact factor: 2.686

Review 2.  Memory T-cell trafficking: new directions for busy commuters.

Authors:  Federica M Marelli-Berg; Hongmei Fu; Fabrizio Vianello; Koji Tokoyoda; Alf Hamann
Journal:  Immunology       Date:  2010-04-12       Impact factor: 7.397

Review 3.  Human copper-dependent amine oxidases.

Authors:  Joel Finney; Hee-Jung Moon; Trey Ronnebaum; Mason Lantz; Minae Mure
Journal:  Arch Biochem Biophys       Date:  2014-01-06       Impact factor: 4.013

4.  CD73 represses pro-inflammatory responses in human endothelial cells.

Authors:  Jana Kg Grünewald; Anne J Ridley
Journal:  J Inflamm (Lond)       Date:  2010-02-05       Impact factor: 4.981

5.  PET imaging of inflammation and adenocarcinoma xenografts using vascular adhesion protein 1 targeting peptide 68Ga-DOTAVAP-P1: comparison with 18F-FDG.

Authors:  Anu Autio; Tiina Ujula; Pauliina Luoto; Satu Salomäki; Sirpa Jalkanen; Anne Roivainen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-06-04       Impact factor: 9.236

6.  Neutrophil elastase induces inflammation and pain in mouse knee joints via activation of proteinase-activated receptor-2.

Authors:  Milind M Muley; Allison R Reid; Bálint Botz; Kata Bölcskei; Zsuzsanna Helyes; Jason J McDougall
Journal:  Br J Pharmacol       Date:  2015-07-31       Impact factor: 8.739

7.  Ecto-5'-nucleotidase expression is associated with the progression of renal cell carcinoma.

Authors:  Y I Yu; Wei Wang; Lei Song; Wentao Hu; Chi Dong; Hailong Pei; Guangming Zhou; Zhongjin Yue
Journal:  Oncol Lett       Date:  2015-04-23       Impact factor: 2.967

8.  Proteolytic cleavage of vascular adhesion protein-1 induced by vascular endothelial growth factor in retinal capillary endothelial cells.

Authors:  Shiho Yoshida; Miyuki Murata; Kousuke Noda; Takashi Matsuda; Michiyuki Saito; Wataru Saito; Atsuhiro Kanda; Susumu Ishida
Journal:  Jpn J Ophthalmol       Date:  2018-02-01       Impact factor: 2.447

Review 9.  Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis.

Authors:  Andrea T Borchers; Shinji Shimoda; Christopher Bowlus; Carl L Keen; M Eric Gershwin
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

Review 10.  The immunobiology of primary sclerosing cholangitis.

Authors:  Jonathan H Aron; Christopher L Bowlus
Journal:  Semin Immunopathol       Date:  2009-05-26       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.